• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在核移植重编程过程中,聚(ADP-核糖)聚合酶1(Parp1)缺陷导致染色质监测和重塑缺陷。

Parp1 Deficiency Confers Defects in Chromatin Surveillance and Remodeling During Reprogramming by Nuclear Transfer.

作者信息

Osada Tomoharu, Nozaki Tadashige, Masutani Mitsuko

机构信息

Drug Development Service Segment LSI Medience Corporation, 13-4, Uchikanda 1-chome, Chiyodaku, Tokyo 101-8517, Japan.

出版信息

Curr Protein Pept Sci. 2016;17(7):693-704. doi: 10.2174/1389203717666160419144502.

DOI:10.2174/1389203717666160419144502
PMID:27090907
Abstract

Accumulating evidence suggests that cloned mice production by the injection of a somatic cell nucleus into an enucleated oocyte is inefficient. DNA damage and chromatin remodeling failures that occur during embryogenesis following nuclear transfer (NT) might explain the poor development of cloned embryos. To avoid these problems, it is important to elucidate somatic chromatin remodeling after NT. Because polyADP-ribosylation, which is catalyzed mainly by poly(ADP-ribose) polymerase 1 (Parp1), is a major post-translational modification that facilitates DNA repair and chromatin remodeling, we examined the effects of Parp1 deficiency in developing NT embryos. Parp1 was located within the pseudo-pronuclei (PPN) of NT eggs. We observed that NT eggs, after activation by Sr2+, formed PPN with significantly more efficiency in Parp1-null embryos than in wild-type NT embryos. However, most the Parp1-null embryos stopped developing by the four-cell stage. Immunostaining for γH2AX foci, a marker of DNA double strand breaks, showed longer retention in the PPN of Parp1-/- donor NT embryos than in wild-type NT embryos, suggesting that, in the absence of Parp1, DNA breaks are slowly repaired and consequently, entry into the S phase might be delayed. Furthermore, decreases in histone H3 acetylation, H3 monomethylation at lysine 4, and H3 trimethylation at lysine 27 after the Sr2+ activation step were observed in the PPN of Parp1-/- donor embryos. Taken together, our data suggest that Parp1 is involved in the plastic remodeling of chromatin structure after NT by supporting DNA repair and specific histone code modifications.

摘要

越来越多的证据表明,通过将体细胞核注入去核卵母细胞来生产克隆小鼠的效率很低。核移植(NT)后胚胎发育过程中发生的DNA损伤和染色质重塑失败可能解释了克隆胚胎发育不良的原因。为了避免这些问题,阐明NT后的体染色质重塑很重要。由于主要由聚(ADP-核糖)聚合酶1(Parp1)催化的聚ADP-核糖基化是一种促进DNA修复和染色质重塑的主要翻译后修饰,我们研究了Parp1缺陷对发育中的NT胚胎的影响。Parp1位于NT卵的假原核(PPN)内。我们观察到,在用Sr2+激活后,NT卵在Parp1基因敲除胚胎中形成PPN的效率明显高于野生型NT胚胎。然而,大多数Parp1基因敲除胚胎在四细胞阶段停止发育。对DNA双链断裂标记物γH2AX焦点的免疫染色显示,Parp1-/-供体NT胚胎的PPN中γH2AX焦点的保留时间比野生型NT胚胎更长,这表明在没有Parp1的情况下,DNA断裂修复缓慢,因此进入S期可能会延迟。此外,在Parp1-/-供体胚胎的PPN中,观察到Sr2+激活步骤后组蛋白H3乙酰化、赖氨酸4处的H3单甲基化和赖氨酸27处的H3三甲基化减少。综上所述,我们的数据表明,Parp1通过支持DNA修复和特定组蛋白密码修饰参与NT后染色质结构的可塑性重塑。

相似文献

1
Parp1 Deficiency Confers Defects in Chromatin Surveillance and Remodeling During Reprogramming by Nuclear Transfer.在核移植重编程过程中,聚(ADP-核糖)聚合酶1(Parp1)缺陷导致染色质监测和重塑缺陷。
Curr Protein Pept Sci. 2016;17(7):693-704. doi: 10.2174/1389203717666160419144502.
2
H3.3 replacement facilitates epigenetic reprogramming of donor nuclei in somatic cell nuclear transfer embryos.H3.3替换有助于体细胞核移植胚胎中供体细胞核的表观遗传重编程。
Nucleus. 2014 Sep-Oct;5(5):369-75. doi: 10.4161/nucl.36231.
3
Poly(ADP-ribosylation) regulates chromatin organization through histone H3 modification and DNA methylation of the first cell cycle of mouse embryos.聚(ADP-核糖基)化通过组蛋白 H3 修饰和胚胎第一次细胞周期的 DNA 甲基化来调节染色质结构。
Biochem Biophys Res Commun. 2013 Apr 26;434(1):15-21. doi: 10.1016/j.bbrc.2013.03.074. Epub 2013 Mar 30.
4
Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways.聚(ADP-核糖)聚合酶PARP1和PARP2与DNA双链断裂修复途径的常见和独特遗传相互作用。
DNA Repair (Amst). 2016 Sep;45:56-62. doi: 10.1016/j.dnarep.2016.06.001. Epub 2016 Jun 16.
5
MORC2 regulates DNA damage response through a PARP1-dependent pathway.MORC2 通过依赖 PARP1 的途径调节 DNA 损伤反应。
Nucleic Acids Res. 2019 Sep 19;47(16):8502-8520. doi: 10.1093/nar/gkz545.
6
Epigenetic modification with trichostatin A does not correct specific errors of somatic cell nuclear transfer at the transcriptomic level; highlighting the non-random nature of oocyte-mediated reprogramming errors.曲古抑菌素A介导的表观遗传修饰并不能在转录组水平上纠正体细胞核移植的特定错误;这凸显了卵母细胞介导的重编程错误的非随机性。
BMC Genomics. 2016 Jan 4;17:16. doi: 10.1186/s12864-015-2264-z.
7
CHD1L Regulated PARP1-Driven Pluripotency and Chromatin Remodeling During the Early-Stage Cell Reprogramming.CHD1L在早期细胞重编程过程中调控PARP1驱动的多能性和染色质重塑。
Stem Cells. 2015 Oct;33(10):2961-72. doi: 10.1002/stem.2116.
8
Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.定义 NSD2 相互作用组:PARP1 的 PAR 化降低 NSD2 组蛋白甲基转移酶活性并阻碍染色质结合。
J Biol Chem. 2019 Aug 16;294(33):12459-12471. doi: 10.1074/jbc.RA118.006159. Epub 2019 Jun 27.
9
Inheritance of histone H3 methylation in reprogramming of somatic nuclei following nuclear transfer.核移植后体细胞核重编程过程中组蛋白H3甲基化的遗传
J Reprod Dev. 2008 Jun;54(3):233-8. doi: 10.1262/jrd.19173. Epub 2008 Apr 14.
10
Reprogramming of fibroblast nuclei in cloned bovine embryos involves major structural remodeling with both striking similarities and differences to nuclear phenotypes of in vitro fertilized embryos.克隆牛胚胎中纤维母细胞核的重编程涉及主要的结构重塑,与体外受精胚胎的核表型既有显著相似之处,也有不同之处。
Nucleus. 2014;5(6):555-89. doi: 10.4161/19491034.2014.979712.

引用本文的文献

1
Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles.PARP抑制剂与5-氮杂脱氧胞苷联合治疗对癌细胞的增强细胞毒性及不同转录谱
Cancers (Basel). 2022 Aug 28;14(17):4171. doi: 10.3390/cancers14174171.
2
RNAi-mediated knockdown of does not improve the development of female cloned mouse embryos.RNA干扰介导的[具体基因或蛋白名称缺失]敲低并不能改善雌性克隆小鼠胚胎的发育。
Oncotarget. 2017 Jul 18;8(41):69863-69873. doi: 10.18632/oncotarget.19418. eCollection 2017 Sep 19.